New hope for waitlisted patients addicted to opioids

December 6, 2017, American College of Neuropsychopharmacology

As the opioid crisis continues to escalate, the number of people who need treatment for their dependency on heroin or prescription pain killers far exceeds the capacity of available treatment programs. People seeking treatment can wait months or even years for spots in clinics or with certified doctors—and while they wait, they risk becoming infected with HIV or hepatitis, as well as dying from an overdose.

Dr. Stacey Sigmon and her team at the University of Vermont's College of Medicine have developed a new intervention for reducing these risks among opioid-dependent people who are stuck on waitlists. The group recently completed a randomized pilot study assessing the feasibility of an interim dosing treatment and found it reduced illicit opioid use and injection drug use among waitlisted patients.

Instead of requiring frequent trips to a doctor or clinic, Dr. Sigmon's approach combines buprenorphine, an effective medication for treating opioid use disorder, with a computerized dispenser that provides only a single dose each day, to be taken at home. The device is equipped with locks and alarms to prevent tampering and ensure that the medication is not misused. The protocol also includes automated phone-based monitoring and random call-back visits for urine testing and pill counts. This regimen allows patients to start potentially life-saving medication immediately, while waiting for access to a community treatment program that includes more comprehensive counseling and other services.

Results from the 12-week study showed that waitlisted, opioid-dependent individuals receiving the interim buprenorphine were significantly better at abstaining from illicit opioid use, as proven by urine tests, compared to those who didn't receive the experimental treatment.

The effectiveness of the interim buprenorphine treatment will soon be the subject of a larger trial, with a focus on testing the treatment in more rural, underserved communities struggling with and limited treatment capacity. In the current, overburdened drug treatment system, Dr. Sigmon's interim therapy could help protect patients from the potentially fatal dangers of illegal use by safely and responsibly providing while they await more intensive .

Explore further: Team reports on study of waitlisted opioid-dependent adults

Related Stories

Team reports on study of waitlisted opioid-dependent adults

December 21, 2016
In rural states like Vermont, opioid-dependent adults desperate for treatment often find themselves stuck on a wait list, sometimes for eight months or more, increasing their risk of continuing to use illicit opioids, contract ...

Police referral without arrest lets opioid abusers seek help

December 27, 2016
(HealthDay)—A direct referral program and use of an interim buprenorphine regimen can be beneficial for encouraging individuals with an opioid-use disorder to seek help, and for reducing drug-related risks, according to ...

Extended-release naltrexone promising for opioid dependence

October 19, 2017
(HealthDay)—Extended-release naltrexone is noninferior to buprenorphine-naloxone for maintaining short-term abstinence from heroin and other illicit substances, according to a study published online Oct. 18 in JAMA Psychiatry.

FDA approves once-monthly injection for opioid addiction

December 4, 2017
(HealthDay)—Sublocade, a once-monthly injection of buprenorphine to treat opioid use disorder, has been approved by the U.S. Food and Drug Administration.

Clinical trial looks at tramadol for opioid withdrawal

July 12, 2017
A randomized clinical trial published by JAMA Psychiatry compared tramadol extended-release with clonidine and buprenorphine for the management of opioid withdrawal symptoms in patients with opioid use disorder in a residential ...

Medicaid patients continue high prescription opioid use after overdose

August 22, 2017
Despite receiving medical attention for an overdose, patients in Pennsylvania Medicaid continued to have persistently high prescription opioid use, with only slight increases in use of medication-assisted treatment, according ...

Recommended for you

Early physical therapy can reduce risk, amount of long-term opioid use, study finds

December 14, 2018
Patients who underwent physical therapy soon after being diagnosed with pain in the shoulder, neck, low back or knee were approximately 7 to 16 percent less likely to use opioids in the subsequent months, according to a new ...

Early postpartum opioids linked with persistent usage

December 14, 2018
Vanderbilt researchers have published findings indicating that regardless of whether a woman delivers a child by cesarean section or by vaginal birth, if they fill prescriptions for opioid pain medications early in the postpartum ...

Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018
Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of ...

Drug wholesalers drove fentanyl's deadly rise, report concludes

December 4, 2018
Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug ...

Global review reports on administration of children's antibiotics

December 4, 2018
Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the ...

Opioid prescriptions from dentists linked to youth addiction risk

December 3, 2018
Teens and young adults who receive their initial opioid prescriptions from their dentists or oral surgeons are at increased risk for opioid addiction in the following year, a study from the Stanford University School of Medicine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.